Trade DYN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Dyne Therapeutics, Inc. (DYN) is trading at US$17.96, down 3.02% today as of Sep 15, 13:14 EDT. The company has a market capitalisation of US$4.87B. Over the past 52 weeks, DYN has traded between US$11.92 and US$27.31. On Syfe you can trade DYN with $0 commission and add it to your watchlist.
| Previous close | US$18.52 |
|---|---|
| Market cap | US$4.87B |
| 52-week range | US$11.92 – US$27.31 |
| Volume | 3.19M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Year: 2020
RBC Raises Price Target on Dyne Therapeutics to $35 From $30, Keeps Outperform, Speculative Risk
Jul 30, 12:30 PM · MT Newswires
Dyne Therapeutics, Inc. (DYN) stock is trading at US$17.96, -3.02% from the previous close of US$18.52.
The market cap for Dyne Therapeutics, Inc. (DYN) stock is approximately US$4.87B.
The 52-week high for Dyne Therapeutics, Inc. (DYN) stock is US$27.31.
The 52-week low for Dyne Therapeutics, Inc. (DYN) stock is US$11.92.
Dyne Therapeutics, Inc. (DYN) does not currently pay a dividend.
Stay on top of DYN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
